|
Re: RVX ANNOUNCES TYPE C MEETING WITH FDA FOR CORAL, A PHASE 3 HIGH-RISK COVID-19 OUTPATIENT STUDY
|
3
|
Resverlogix Corp.
|
May 09, 2022 05:09PM
|
|
Re: RVX ANNOUNCES TYPE C MEETING WITH FDA FOR CORAL, A PHASE 3 HIGH-RISK COVID-19 OUTPATIENT STUDY
|
2
|
Resverlogix Corp.
|
May 09, 2022 03:16PM
|
|
Re: RVX ANNOUNCES TYPE C MEETING WITH FDA FOR CORAL, A PHASE 3 HIGH-RISK COVID-19 OUTPATIENT STUDY
|
7
|
Resverlogix Corp.
|
May 09, 2022 12:07PM
|
|
Re: RVX ANNOUNCES TYPE C MEETING WITH FDA FOR CORAL, A PHASE 3 HIGH-RISK COVID-19 OUTPATIENT STUDY
|
1
|
Resverlogix Corp.
|
May 09, 2022 09:26AM
|
|
Re: " Resverlogix will conclude its Phase 2 trial in hospitalized COVID-19 patients early, thus focusing its resources on the advanced Phase 3 program."
|
3
|
Resverlogix Corp.
|
May 09, 2022 09:04AM
|
|
RVX ANNOUNCES TYPE C MEETING WITH FDA FOR CORAL, A PHASE 3 HIGH-RISK COVID-19 OUTPATIENT STUDY
|
2
|
Resverlogix Corp.
|
May 09, 2022 07:42AM
|
|
Re: IR response
|
1
|
Resverlogix Corp.
|
May 06, 2022 10:31PM
|
|
Re: keep doing PPs at .48/shr with a .50 warrant good till 2025 donny
|
1
|
Resverlogix Corp.
|
May 06, 2022 10:53AM
|
|
Re: IR response
|
1
|
Resverlogix Corp.
|
May 06, 2022 10:35AM
|
|
Re: IR response
|
3
|
Resverlogix Corp.
|
May 06, 2022 10:15AM
|
|
Re: Pfizer sees strong demand for COVID pill as profits surge.
|
5
|
Resverlogix Corp.
|
May 04, 2022 07:15PM
|
|
Re: A couple of things
|
1
|
Resverlogix Corp.
|
May 03, 2022 09:33AM
|
|
Re: Market Woes
|
4
|
Resverlogix Corp.
|
May 01, 2022 07:57PM
|
|
Re: Market Woes
|
2
|
Resverlogix Corp.
|
May 01, 2022 10:09AM
|
|
Re: Market Woes
|
1
|
Resverlogix Corp.
|
Apr 30, 2022 07:42PM
|
|
Re: New Apabetalone Fabry Disease Publication
|
1
|
Resverlogix Corp.
|
Apr 29, 2022 03:37PM
|
|
Re: New Apabetalone Fabry Disease Publication
|
4
|
Resverlogix Corp.
|
Apr 29, 2022 03:17PM
|
|
Re: New Apabetalone Fabry Disease Publication
|
2
|
Resverlogix Corp.
|
Apr 29, 2022 02:45PM
|
|
Re: New Apabetalone Fabry Disease Publication
|
4
|
Resverlogix Corp.
|
Apr 28, 2022 06:31AM
|
|
Re: BIOAF
|
1
|
BIOASIS TECHNOLOGIES INC
|
Apr 25, 2022 03:36PM
|
